Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
Study sponsor: NovoCure GmbH
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-06-20Actual
Enrollment · participants25Actual
Source updated2024-08-16Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.